Literature DB >> 33325024

Considerations for scuba and breath-hold divers during the COVID-19 pandemic: A call for awareness.

Antonis Elia1,2, Mikael Gennser1.   

Abstract

In late 2019, a highly pathogenic novel coronavirus (CoV), severe acute respiratory syndrome (SARS)-CoV-2 emerged from Wuhan, China and led to a global pandemic. SARS-CoV-2 has a predilection for the pulmonary system and can result in serious pneumonia necessitating hospitalisation. Computed tomography (CT) chest scans of patients with severe symptoms, show signs of multifocal bilateral ground or ground-glass opacities (GGO) associated with consolidation areas with patchy distribution. However, it is less well known that both asymptomatic and mild symptomatic patients may exhibit similar lung changes. Presumably, the various pathological changes in the lungs may increase the risk of adverse events during diving (e.g., lung barotrauma, pulmonary oedema, etc.), thus these lung manifestations need to be considered prior to allowing resumption of diving. Presently, it is not known how the structural changes in the lungs develop and to what extent they resolve, in particular in asymptomatic carriers and patients with mild disease. However, current evidence indicates that a month of recovery may be too short an interval to guarantee complete pulmonary restitution even after COVID-19 infections not demanding hospital care. Copyright: This article is the copyright of the authors who grant Diving and Hyperbaric Medicine a non-exclusive licence to publish the article in electronic and other forms.

Entities:  

Keywords:  Apnoea; Breath-hold diving; COVID-19; Hypoxaemia; Lungs; SARS-CoV-2; Scuba diving

Mesh:

Year:  2020        PMID: 33325024      PMCID: PMC8026225          DOI: 10.28920/dhm50.4.413-416

Source DB:  PubMed          Journal:  Diving Hyperb Med        ISSN: 1833-3516            Impact factor:   0.887


  20 in total

1.  Severe acute respiratory syndrome: thin-section computed tomography features, temporal changes, and clinicoradiologic correlation during the convalescent period.

Authors:  Ka-tak Wong; Gregory E Antonio; David S C Hui; Catherine Ho; Po-nin Chan; Wing-hung Ng; Kwok-kuen Shing; Alan Wu; Nelson Lee; Florence Yap; Gavin M Joynt; Joseph J Y Sung; Anil T Ahuja
Journal:  J Comput Assist Tomogr       Date:  2004 Nov-Dec       Impact factor: 1.826

2.  Dynamic changes of serum SARS-coronavirus IgG, pulmonary function and radiography in patients recovering from SARS after hospital discharge.

Authors:  Lixin Xie; Youning Liu; Baoxing Fan; Yueyong Xiao; Qing Tian; Liangan Chen; Hong Zhao; Weijun Chen
Journal:  Respir Res       Date:  2005-01-08

3.  Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis.

Authors:  Jean-Christophe Lagier; Matthieu Million; Philippe Gautret; Philippe Colson; Sébastien Cortaredona; Audrey Giraud-Gatineau; Stéphane Honoré; Jean-Yves Gaubert; Pierre-Edouard Fournier; Hervé Tissot-Dupont; Eric Chabrière; Andreas Stein; Jean-Claude Deharo; Florence Fenollar; Jean-Marc Rolain; Yolande Obadia; Alexis Jacquier; Bernard La Scola; Philippe Brouqui; Michel Drancourt; Philippe Parola; Didier Raoult
Journal:  Travel Med Infect Dis       Date:  2020-06-25       Impact factor: 6.211

4.  Secondary tension pneumothorax in a COVID-19 pneumonia patient: a case report.

Authors:  Judith E Spiro; Snezana Sisovic; Ben Ockert; Wolfgang Böcker; Georg Siebenbürger
Journal:  Infection       Date:  2020-06-18       Impact factor: 3.553

5.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.

Authors:  Roujian Lu; Xiang Zhao; Juan Li; Peihua Niu; Bo Yang; Honglong Wu; Wenling Wang; Hao Song; Baoying Huang; Na Zhu; Yuhai Bi; Xuejun Ma; Faxian Zhan; Liang Wang; Tao Hu; Hong Zhou; Zhenhong Hu; Weimin Zhou; Li Zhao; Jing Chen; Yao Meng; Ji Wang; Yang Lin; Jianying Yuan; Zhihao Xie; Jinmin Ma; William J Liu; Dayan Wang; Wenbo Xu; Edward C Holmes; George F Gao; Guizhen Wu; Weijun Chen; Weifeng Shi; Wenjie Tan
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

6.  Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study.

Authors:  Peixun Zhang; Jia Li; Huixin Liu; Na Han; Jiabao Ju; Yuhui Kou; Lei Chen; Mengxi Jiang; Feng Pan; Yali Zheng; Zhancheng Gao; Baoguo Jiang
Journal:  Bone Res       Date:  2020-02-14       Impact factor: 13.567

7.  Comparison of clinical and epidemiological characteristics of asymptomatic and symptomatic SARS-CoV-2 infection: A multi-center study in Sichuan Province, China.

Authors:  Weifang Kong; Yuting Wang; Jinliang Hu; Aamer Chughtai; Hong Pu
Journal:  Travel Med Infect Dis       Date:  2020-05-31       Impact factor: 6.211

Review 8.  From SARS to MERS, Thrusting Coronaviruses into the Spotlight.

Authors:  Zhiqi Song; Yanfeng Xu; Linlin Bao; Ling Zhang; Pin Yu; Yajin Qu; Hua Zhu; Wenjie Zhao; Yunlin Han; Chuan Qin
Journal:  Viruses       Date:  2019-01-14       Impact factor: 5.048

9.  COVID-19 pneumonia: different respiratory treatments for different phenotypes?

Authors:  Luciano Gattinoni; Davide Chiumello; Pietro Caironi; Mattia Busana; Federica Romitti; Luca Brazzi; Luigi Camporota
Journal:  Intensive Care Med       Date:  2020-04-14       Impact factor: 17.440

10.  CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan, China.

Authors:  Heng Meng; Rui Xiong; Ruyuan He; Weichen Lin; Bo Hao; Lin Zhang; Zilong Lu; Xiaokang Shen; Tao Fan; Wenyang Jiang; Wenbin Yang; Tao Li; Jun Chen; Qing Geng
Journal:  J Infect       Date:  2020-04-12       Impact factor: 6.072

View more
  2 in total

1.  Post COVID-19 fitness to dive assessment findings in occupational and recreational divers.

Authors:  Bengusu Mirasoglu; Gulsen Yetis; Mustafa Erelel; Akin Savas Toklu
Journal:  Diving Hyperb Med       Date:  2022-03-31       Impact factor: 1.228

2.  Return to diving after COVID-19.

Authors:  Kay Tetzlaff
Journal:  Eur J Prev Cardiol       Date:  2022-07-20       Impact factor: 8.526

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.